Spark Biomedical Inc

United States - Dallas, Texas

• 01/05/2025
• Series A
• $15,000,000

Revolutionizing healthcare as pioneers in non-invasive neurostimulation solutions.

At Spark Biomedical, we are defined by our boldness, agility, and collaborative spirit. Committed to unlocking the potential of neurostimulation technology for diverse health challenges. We aim to equip providers and researchers with innovative, evidence-based solutions that redefine approaches to treatment -- inspired by our commitment to offer more to patients.

Our journey began in Dallas in 2018, where we broke barriers with the Sparrow Therapy System, the first generation of our safe, comfortable, drug-free, and FDA-cleared approach to treating opioid withdrawal symptoms. Today, our second-generation device, Sparrow Ascent is spreading its wings and expanding its impact as we explore more ways to bend the curve on opioid addiction.

We are Spark Biomedical – a center for groundbreaking neurostimulation technology, cutting-edge scientific research, and compassionate patient support.
We are Spark Biomedical and we’re here to change the world.

Related People

Daniel PowellFounder

United States - Dallas, Texas

"it's not the critic who counts; not the man who points out how the strong man stumbles, or where the doer of deeds could have done them better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood; who strives valiantly...who at the best knows in the end the triumph of high achievement, and who at the worst, if he fails, at least fails while daring greatly." - Teddy Roosevelt

Daniel Powell has over 25 years of experience delivering technical solutions across multiple industries. In 2006, Mr. Powell found his true passion in medical devices, specifically neurostimulation, and has since launched multiple products in the space, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for Epilepsy. Mr. Powell co-founded and serves as CEO of Spark Biomedical, the developer of the FDA-cleared Sparrow Ascent; a novel, wearable neurostimulation solution to address opioid withdrawal and addiction for adults. Under Mr. Powell's leadership, Spark continues to advance the science of wearable neurostimulation and is developing a solution for Neonatal Opioid Withdrawal Syndrome - addressing the most vulnerable victims of the opioid epidemic, newborn babies.

LinkedIn https://www.linkedin.com/in/daniel-powell-a377055/